Leflunomid (Leflunomide), Federal Court of Justice (Bundesgerichtshof), 24 July 2012
July 14, 2013
and Bernd Kröger.
A combination of two pharmaceutical ingredients, i.e. leflunomide and teriflunomide is to be considered obvious if the person skilled in the art uses an obvious process to obtain leflunomide that automatically results in - even with a certain delay - both components due to a chemical reaction.
Click here for the full text of this case.
A summary of this case will be posted on http://www.Kluweriplaw.com
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
You may also like
June 24, 2025